142 related articles for article (PubMed ID: 9661621)
1. Somatostatin and somatostatin receptor subtype gene expression in medullary thyroid carcinoma.
Mato E; Matías-Guiu X; Chico A; Webb SM; Cabezas R; Berná L; De Leiva A
J Clin Endocrinol Metab; 1998 Jul; 83(7):2417-20. PubMed ID: 9661621
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin receptor subtype gene expression in pituitary adenomas.
Miller GM; Alexander JM; Bikkal HA; Katznelson L; Zervas NT; Klibanski A
J Clin Endocrinol Metab; 1995 Apr; 80(4):1386-92. PubMed ID: 7714115
[TBL] [Abstract][Full Text] [Related]
3. Use of somatostatin analogue scintigraphy in the localization of recurrent medullary thyroid carcinoma.
Bernà L; Chico A; Matías-Guiu X; Mato E; Catafau A; Alonso C; Mora J; Mauricio D; Rodríguez-Espinosa J; Marí C; Flotats A; Martín JC; Estorch M; Carrió I
Eur J Nucl Med; 1998 Nov; 25(11):1482-8. PubMed ID: 9799343
[TBL] [Abstract][Full Text] [Related]
4. Characterization of cloned somatostatin receptors SSTR4 and SSTR5.
Raynor K; O'Carroll AM; Kong H; Yasuda K; Mahan LC; Bell GI; Reisine T
Mol Pharmacol; 1993 Aug; 44(2):385-92. PubMed ID: 8102785
[TBL] [Abstract][Full Text] [Related]
5. Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: potential clinical perspectives.
Zatelli MC; Piccin D; Tagliati F; Bottoni A; Luchin A; Vignali C; Margutti A; Bondanelli M; Pansini GC; Pelizzo MR; Culler MD; Degli Uberti EC
J Clin Endocrinol Metab; 2006 Jun; 91(6):2218-24. PubMed ID: 16569735
[TBL] [Abstract][Full Text] [Related]
6. Expression of somatostatin receptor (SSTR) subtypes in pituitary adenomas: quantitative analysis of SSTR2 mRNA by reverse transcription-polymerase chain reaction.
Murabe H; Shimatsu A; Ihara C; Mizuta H; Nakamura Y; Nagata I; Kikuchi H; Nakao K
J Neuroendocrinol; 1996 Aug; 8(8):605-10. PubMed ID: 8866248
[TBL] [Abstract][Full Text] [Related]
7. Somatostatin receptor subtype 1 might be a predictor of better response to therapy in medullary thyroid carcinoma.
Kendler DB; Araújo ML; Alencar R; de Souza Accioly MT; Bulzico DA; de Noronha Pessoa CC; Accioly FA; de Farias TP; Lopes FPPL; Corbo R; Vaisman M; Vaisman F
Endocrine; 2017 Dec; 58(3):474-480. PubMed ID: 28948577
[TBL] [Abstract][Full Text] [Related]
8. Pituitary and hypothalamic somatostatin receptor subtype messenger ribonucleic acid expression in the food-deprived and diabetic rat.
Bruno JF; Xu Y; Song J; Berelowitz M
Endocrinology; 1994 Nov; 135(5):1787-92. PubMed ID: 7956902
[TBL] [Abstract][Full Text] [Related]
9. Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides.
Raynor K; Murphy WA; Coy DH; Taylor JE; Moreau JP; Yasuda K; Bell GI; Reisine T
Mol Pharmacol; 1993 Jun; 43(6):838-44. PubMed ID: 8100350
[TBL] [Abstract][Full Text] [Related]
10. SRC homology-2-containing protein tyrosine phosphatase-1 restrains cell proliferation in human medullary thyroid carcinoma.
Zatelli MC; Piccin D; Tagliati F; Bottoni A; Luchin A; degli Uberti EC
Endocrinology; 2005 Jun; 146(6):2692-8. PubMed ID: 15746253
[TBL] [Abstract][Full Text] [Related]
11. Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors.
Kubota A; Yamada Y; Kagimoto S; Shimatsu A; Imamura M; Tsuda K; Imura H; Seino S; Seino Y
J Clin Invest; 1994 Mar; 93(3):1321-5. PubMed ID: 8132773
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical detection of somatostatin receptor types 1-5 in medullary carcinoma of the thyroid.
Papotti M; Kumar U; Volante M; Pecchioni C; Patel YC
Clin Endocrinol (Oxf); 2001 May; 54(5):641-9. PubMed ID: 11380495
[TBL] [Abstract][Full Text] [Related]
13. 111In-DTPA-D-Phe1-octreotide binding and somatostatin receptor subtypes in thyroid tumors.
Forssell-Aronsson EB; Nilsson O; Bejegård SA; Kölby L; Bernhardt P; Mölne J; Hashemi SH; Wängberg B; Tisell LE; Ahlman H
J Nucl Med; 2000 Apr; 41(4):636-42. PubMed ID: 10768564
[TBL] [Abstract][Full Text] [Related]
14. Somatostatin regulates somatostatin receptor subtype mRNA expression in GH3 cells.
Bruno JF; Xu Y; Berelowitz M
Biochem Biophys Res Commun; 1994 Aug; 202(3):1738-43. PubMed ID: 7914724
[TBL] [Abstract][Full Text] [Related]
15. Somatostatin receptors and somatostatin content in medullary thyroid carcinomas.
Reubi JC; Chayvialle JA; Franc B; Cohen R; Calmettes C; Modigliani E
Lab Invest; 1991 Apr; 64(4):567-73. PubMed ID: 1673164
[TBL] [Abstract][Full Text] [Related]
16. Expression and localization of somatostatin receptor SSTR1, SSTR2, and SSTR3 messenger RNAs in primary human tumors using in situ hybridization.
Reubi JC; Schaer JC; Waser B; Mengod G
Cancer Res; 1994 Jul; 54(13):3455-9. PubMed ID: 8012966
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin receptor subtype expression in human thyroid and thyroid carcinoma cell lines.
Ain KB; Taylor KD; Tofiq S; Venkataraman G
J Clin Endocrinol Metab; 1997 Jun; 82(6):1857-62. PubMed ID: 9177396
[TBL] [Abstract][Full Text] [Related]
18. SRIF receptor subtype expression and involvement in positive and negative contractile effects of somatostatin-14 (SRIF-14) in ventricular cardiomyocytes.
Bell D; Zhao Y; McMaster B; McHenry EM; Wang X; Kelso EJ; McDermott BJ
Cell Physiol Biochem; 2008; 22(5-6):653-64. PubMed ID: 19088447
[TBL] [Abstract][Full Text] [Related]
19. Somatostatin receptor subtypes, octreotide scintigraphy, and clinical response to octreotide treatment in patients with neuroendocrine tumors.
Kölby L; Wängberg B; Ahlman H; Tisell LE; Fjälling M; Forssell-Aronsson E; Nilsson O
World J Surg; 1998 Jul; 22(7):679-83. PubMed ID: 9606281
[TBL] [Abstract][Full Text] [Related]
20. Somatostatin production by a human medullary thyroid carcinoma cell line.
Gagel RF; Palmer WN; Leonhart K; Chan L; Leong SS
Endocrinology; 1986 Apr; 118(4):1643-51. PubMed ID: 2868883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
